Abstract
Most radiopharmaceuticals are used for the purpose of medical diagnosis. They usually contain only small amounts of the active substances with a radionuclide attached to them to allow scintigraphic imaging or measurement of the biodistribution. In the case of therapeutic radiopharmaceuticals, the radiation effect is the target property. Evaluation of the safety and efficacy of radiopharmaceuticals should include radiopharmaceutical and radiation protection aspects and radiation dosimetry in addition to general parameters. The principal characteristics and the main clinical indications of some radiopharmaceuticals with use in endocrinology are presented in Chap. 6.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Further Reading
Chilton HM, Witcofski RL (1986) Nuclear pharmacy. An introduction to the clinical applications of radiopharmaceuticals. Lea and Fiebiger, Philadelphia
Henkin RE, Boles MA, Dillehay GL et al (1996) The scientific basis of nuclear medicine; Part IIB: radiopharmacy. In: Nuclear medicine. Mosby, New York
Hung JC, Ponto JA, Hammes RI (1996) Radiopharmaceutical- related pitfalls and artifacts. Semin Nucl Med 26:208–255
IAEA (2007) Comparative evaluation of therapeutic radiopharmaceuticals. Technical reports series no. 458 STI/Doc/010/458
Ishibashi M et al (1998) Comparison of technetium-99m-MIBI, technetium-99m- tetrofosmin, ultrasound and MRI for localization of abnormal parathyroid glands. J Nucl Med 39:320–324
Kowalsky RJ, Perry JR (1987) Radiopharmaceuticals. In: Nuclear medicine. Appleton&Lange, Norwalk
Palmer EL, Scott JA, Strauss HW (1992) Radiation and radionuclides. In: Practical nuclear medicine. WB Saunders Company, Philadelphia, pp 57–71
Rubello D, Mariani G, Pelizzo MR, Giscris A (2007) Minimally invasive radio-guided parathyroidectomy on a group of 452 primary hyperparathyroid patients – refinement of preoperative imaging and intraoperative procedure. Nuklearmedizin 46:85–92
Rubow SM, Ellmann A, Leroux J, Klopper J (1991) Excretion of Tc-99m hexakismethoxyisobutylisonitrile in milk. Eur J Nucl Med 18:363–365
Saha GB (1992) Fundamentals of nuclear pharmacy, 4th edn. Springer, New York
Sampson CB (1999) Textbook of radiopharmacy: theory and practice, 3rd edn. Gordon and Breach Science Publishers, Amsterdam
Sharp PF, Gemmell H, Murray A (eds) (2005) Practical nuclear medicine, 3rd edn. Springer, New York, pp 113–143
Thakur ML (2003) New radiopharmaceuticals in oncologic diagnosis and therapy. Cancer Biother Radiopharm 18:276
Williams LE (2010) Radiopharmaceuticals – introduction to drug evaluation and dose estimation. CRC Press/Taylor & Francis Group, Boca Raton
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2012 Springer-Verlag GmbH Berlin Heidelberg
About this chapter
Cite this chapter
Piciu, D. (2012). Radiopharmaceuticals. In: Nuclear Endocrinology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-25014-9_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-25014-9_6
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-25013-2
Online ISBN: 978-3-642-25014-9
eBook Packages: MedicineMedicine (R0)